AXSM Axsome Therapeutics Inc

Axsome Therapeutics Inc is a pharmaceutical company in the United States. It focusses on developing novel therapeutics for the redressal of diseases related to the central nervous system.

$46.09  -0.88 (-1.86%)
As of 10/05/2022 15:59:55 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  11/19/2015
Outstanding shares:  38,913,550
Average volume:  1,165,530
Market cap:   $1,763,951,222
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BYZR4X4
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   124.23
PS ratio:   0.00
Return on equity:   -887,941.67%
Net income %:   0.00%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy